What is the current Agricultural Animal Vaccine market size?

The current Agricultural Animal Vaccine market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Agricultural Animal Vaccine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Agricultural Animal Vaccine market?

Key drivers include rising animal disease outbreaks and growing awareness of animal health, driving future outlook.

What are the major challenges facing the Agricultural Animal Vaccine market?

Challenges include high development costs and stringent regulatory frameworks, impacting market growth.

Which regions are leading the Agricultural Animal Vaccine market?

North America and Europe are regional leaders, accounting for over 60% of the global market share.

Who are the top companies in the Agricultural Animal Vaccine market?

Top companies include Zoetis, Merck, and Boehringer Ingelheim, driving innovation and growth.

What future opportunities exist in the Agricultural Animal Vaccine market?

Emerging markets and advancements in vaccine technology present significant future opportunities for growth.

How is technology impacting the Agricultural Animal Vaccine market?

Advances in biotechnology and digitalization are improving vaccine development, distribution, and administration.

What is the current regulatory landscape for the Agricultural Animal Vaccine market?

Regulatory frameworks vary by region, with stringent guidelines in place to ensure vaccine safety and efficacy.

How will the Agricultural Animal Vaccine market evolve in the next 5 years?

The market will evolve through increased adoption of novel vaccine technologies and expansion into emerging markets.

Agricultural Animal Vaccine Expansion Opportunities & Forecast Analysis 2033

Agricultural Animal Vaccine by Application (Cow, Sheep, Swine, Chicken, Others), by Types (Live Attenuated Vaccines, Inactivated Vaccines, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $12.1 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $12.1 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 10, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Agricultural Animal Vaccine Market Overview

The Agricultural Animal Vaccine market is a crucial segment of the animal health industry, playing a vital role in preventing and controlling diseases in livestock. As the global demand for animal-derived food products continues to rise, the Agricultural Animal Vaccine market size is estimated to be around $8.5 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2026 to 2033. This industry expansion is driven by factors such as increasing awareness about animal health, advancements in vaccine technology, and rising concerns about zoonotic diseases. The scope of this market encompasses various types of vaccines, including live attenuated, inactivated, and subunit vaccines, which are used to prevent diseases in livestock such as cattle, pigs, chickens, and fish.

Loading chart…

Key forces shaping the Agricultural Animal Vaccine industry include technology shifts towards more effective and safer vaccines, regulations governing the use of vaccines in different regions, and consumer behavior driven by increasing awareness about animal health. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing demand for animal-derived food products and rising awareness about animal health. The market is expected to witness significant growth during the forecast period, driven by the increasing adoption of vaccines in the livestock industry and the rising demand for animal-derived food products.

Report Overview

Report Attribute	Details
Market size value in 2025	12.10 million
Revenue forecast in 2033	22.07 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Zoetis; Boehringer Ingelheim; Ceva Corporate; HVRI; Ringpu Biology; Yebio Bioengineering; Guangdong Wenshi Dahuanong Biotechnology; Virbac; Jinyu Bio-Technology; ChengDu Tecbond; CHOONGANG VACCINE; FATRO
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Agricultural Animal Vaccine market is poised for significant growth, driven by increasing demand for animal protein and rising concerns over animal health. The market dynamics are complex, influenced by various factors that impact the Agricultural Animal Vaccine market size and growth forecast.

Growth Drivers2 items

Advances in vaccine technology, such as the development of subunit vaccines and DNA vaccines, are improving the efficacy and safety of Agricultural Animal Vaccines, driving adoption and growth in the market.

Government initiatives and regulatory frameworks supporting animal health and vaccination programs are also contributing to the growth of the Agricultural Animal Vaccine market, particularly in developing regions.

Restraints2 items

High development costs and time-consuming regulatory approval processes for new Agricultural Animal Vaccines can limit the entry of new players and hinder market growth, affecting the overall Agricultural Animal Vaccine market size.

The complexity of animal disease diagnosis and vaccination strategies can also create challenges for farmers and veterinarians, potentially restraining the growth of the Agricultural Animal Vaccine market.

Opportunities2 items

The increasing demand for animal protein and rising concerns over antimicrobial resistance are creating opportunities for the development of innovative and effective Agricultural Animal Vaccines, driving growth in the market.

The growing trend of veterinary care and animal health consciousness among farmers and pet owners is also expected to drive the adoption of Agricultural Animal Vaccines, contributing to a positive growth forecast.

Challenges2 items

The global supply chain disruptions and trade tensions can impact the availability and affordability of Agricultural Animal Vaccines, posing challenges for the market and affecting the Agricultural Animal Vaccine market size.

The need for continuous monitoring and evaluation of Agricultural Animal Vaccines to ensure their safety and efficacy is also a significant challenge, requiring substantial investment and resources from manufacturers and regulatory authorities.

Market Segmentation

Loading chart…

The Agricultural Animal Vaccine market can be segmented based on Application, which refers to the specific use of vaccines in different animal species. This segmentation category contributes significantly to the overall market size, as various animal species require distinct vaccine formulations. The application segment is further divided into subtypes, including livestock, companion animals, and others. Understanding the Agricultural Animal Vaccine segmentation by application is crucial for manufacturers to develop targeted products and marketing strategies.

Another key segmentation category in the Agricultural Animal Vaccine market is Types, which encompasses various vaccine formats, such as inactivated vaccines, live attenuated vaccines, and toxoid vaccines. This segmentation category plays a vital role in determining the market size, as different vaccine types have distinct production processes, storage requirements, and administration protocols. The types segment is also sub-divided into subtypes, including conjugate vaccines, recombinant vaccines, and others. Analyzing the market taxonomy by types helps stakeholders identify trends and opportunities in the development of innovative vaccine products.

Agricultural Animal Vaccine Segmentation Breakdown10 items

Application

Cow

Sheep

Swine

Chicken

Others

Types

Live Attenuated Vaccines

Inactivated Vaccines

Others

Regional Insights

Loading chart…

The Agricultural Animal Vaccine market growth is expected to vary across regions, with the Asia Pacific region being the largest, accounting for approximately 35% of the market share, and also the fastest-growing region, driven by increasing adoption of animal vaccines, supportive policies, and significant investments in the agricultural sector.

Key drivers for each region include: for North America, infrastructure and ecosystem maturity; for Europe, demographics and regulatory frameworks; for Asia Pacific, government initiatives and rising demand for animal products; for Latin America, expanding livestock production and increasing awareness about animal health; and for Middle East & Africa, growing food demand and improving healthcare infrastructure.

The regional forecast indicates that the Agricultural Animal Vaccine market will experience significant growth in the coming years, driven by factors such as urbanization, increasing animal disease outbreaks, and advancements in vaccine technology. Understanding these regional trends is crucial for stakeholders to capitalize on the growing demand for animal vaccines and contribute to the overall Agricultural Animal Vaccine market growth.

Competitive Landscape

The Agricultural Animal Vaccine market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the Agricultural Animal Vaccine competitive landscape is crucial for navigating this complex market, where companies must balance these levers to maintain market share.

Companies employ various strategies to differentiate themselves, such as M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges like margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, firms focus on unique value propositions, including technology, service models, channel strength, customization, and cost advantages. Key companies' strategies include:

Merck: regional expansion

Zoetis: premium pricing

Boehringer Ingelheim: innovation pipeline

Ceva Corporate: local manufacturing

HVRI: OEM tie-ups

Ringpu Biology: vertical integration

Key Agricultural Animal Vaccine Companies13 items

Merck

Zoetis

Boehringer Ingelheim

Ceva Corporate

HVRI

Ringpu Biology

Yebio Bioengineering

Guangdong Wenshi Dahuanong Biotechnology

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CHOONGANG VACCINE

FATRO

Market Ecosystem

The Agricultural Animal Vaccine ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly categorized into three segments: upstream, midstream, and downstream. Upstream participants provide raw materials and components, while midstream entities integrate these inputs into final products. Downstream channels and end users ultimately receive and utilize these products, creating and capturing value through their interactions.

Raw material suppliers — providing vaccine components

Technology providers — developing vaccine technologies

OEMs/manufacturers — producing animal vaccines

Distributors/channel partners — delivering vaccines to end users

Service providers/after-sales — offering support and maintenance services

End users/buyers — utilizing animal vaccines in agricultural settings

Regulators/standards bodies — establishing and enforcing vaccine standards

Within the Agricultural Animal Vaccine ecosystem, value flows through the interactions and relationships among these participants. Control points, such as regulatory approvals and industry standards, influence the adoption of vaccines. Dependency risks, including input constraints and approval processes, can impact the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can affect the dynamics of this ecosystem, which may differ by region due to varying regulatory frameworks and market conditions, highlighting the need for a thorough value chain analysis.

Recent Industry Insights

The Agricultural Animal Vaccine industry trends have witnessed significant developments over the last 12-18 months. Recently, there have been notable partnerships, such as collaborations between vaccine manufacturers and research institutions, aimed at developing innovative vaccine solutions. Additionally, the industry has seen several mergers and acquisitions, with major players expanding their product portfolios and strengthening their market presence.

Furthermore, the launch of new products and technologies has been a key focus area, with companies investing in advanced vaccine development platforms and improved manufacturing processes. Regulatory changes have also played a crucial role, with updates to vaccination guidelines and protocols driving demand for specific vaccine types. The shift in consumer and enterprise trends towards sustainable and animal-friendly practices has also influenced the Agricultural Animal Vaccine industry trends, with companies adapting to these changes through strategic funding rounds and expansions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Agricultural Animal Vaccine market outlook. The market exhibits high attractiveness due to increasing demand for animal health products and a rising focus on food safety. The competitive intensity is moderate, with key players investing in research and development to enhance their product portfolios. The long-term outlook remains positive, driven by growing concerns about zoonotic diseases and the need for effective vaccination programs.

The innovation landscape is evolving, with advancements in vaccine technologies and delivery systems. However, the demand–supply balance may be affected by factors such as regulatory changes and disease outbreaks. Key risk factors include market volatility and competition from alternative products. Overall, the Agricultural Animal Vaccine market is expected to experience steady growth, driven by increasing awareness about animal health and the importance of vaccination in preventing diseases.

11 items

1. Executive Summary

2. Agricultural Animal Vaccine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Agricultural Animal Vaccine Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Agricultural Animal Vaccine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cow

6.1.2. Sheep

6.1.3. Swine

6.1.4. Chicken

6.1.5. Others

6.2. Global Agricultural Animal Vaccine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Live Attenuated Vaccines

6.2.2. Inactivated Vaccines

6.2.3. Others

6.3. Global Agricultural Animal Vaccine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Agricultural Animal Vaccine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Agricultural Animal Vaccine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Agricultural Animal Vaccine Market Competition by Key Manufacturers

8.1. Global Agricultural Animal Vaccine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Agricultural Animal Vaccine: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zoetis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boehringer Ingelheim

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Ceva Corporate

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. HVRI

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Ringpu Biology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Yebio Bioengineering

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Guangdong Wenshi Dahuanong Biotechnology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Virbac

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Jinyu Bio-Technology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ChengDu Tecbond

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. CHOONGANG VACCINE

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. FATRO

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Agricultural Animal Vaccine Market

Figure 4: Global Agricultural Animal Vaccine Market: Drivers

Figure 5: Global Agricultural Animal Vaccine Market: Challenges

Figure 6: Global Agricultural Animal Vaccine Market: Trends

Figure 7: Global Agricultural Animal Vaccine Market: Opportunity

Figure 8: Global Agricultural Animal Vaccine Market: Restraint

Figure 9: Global Agricultural Animal Vaccine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Agricultural Animal Vaccine Market Value (USD Million) By Region

Figure 15: Global Agricultural Animal Vaccine Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Agricultural Animal Vaccine Market Value (USD Million) By Region

Figure 23: Global Agricultural Animal Vaccine Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Agricultural Animal Vaccine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Agricultural Animal Vaccine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Agricultural Animal Vaccine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Agricultural Animal Vaccine Market Value (USD Million) By Region

Table 10: Global Agricultural Animal Vaccine Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Agricultural Animal Vaccine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Agricultural Animal Vaccine Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Agricultural Animal Vaccine Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck Basic Information And Sales Area

Table 31: Merck. Products Portfolio

Table 32: Zoetis Basic Information And Sales Area

Table 33: Zoetis. Products Portfolio

Table 34: Boehringer Ingelheim Basic Information And Sales Area

Table 35: Boehringer Ingelheim. Products Portfolio

Table 36: Ceva Corporate Basic Information And Sales Area

Table 37: Ceva Corporate. Products Portfolio

Table 38: HVRI Basic Information And Sales Area

Table 39: HVRI. Products Portfolio

Table 40: Ringpu Biology Basic Information And Sales Area

Table 41: Ringpu Biology. Products Portfolio

Table 42: Yebio Bioengineering Basic Information And Sales Area

Table 43: Yebio Bioengineering. Products Portfolio

Table 44: Guangdong Wenshi Dahuanong Biotechnology Basic Information And Sales Area

Table 45: Guangdong Wenshi Dahuanong Biotechnology. Products Portfolio

Table 46: Virbac Basic Information And Sales Area

Table 47: Virbac. Products Portfolio

Table 48: Jinyu Bio-Technology Basic Information And Sales Area

Table 49: Jinyu Bio-Technology. Products Portfolio

Table 50: ChengDu Tecbond Basic Information And Sales Area

Table 51: ChengDu Tecbond. Products Portfolio

Table 52: CHOONGANG VACCINE Basic Information And Sales Area

Table 53: CHOONGANG VACCINE. Products Portfolio

Table 54: FATRO Basic Information And Sales Area

Table 55: FATRO. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Agricultural Animal Vaccine Market Value (USD Million) By Region

Table 61: Global Agricultural Animal Vaccine Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Agricultural Animal Vaccine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.10 million
Revenue forecast in 2033	22.07 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Zoetis; Boehringer Ingelheim; Ceva Corporate; HVRI; Ringpu Biology; Yebio Bioengineering; Guangdong Wenshi Dahuanong Biotechnology; Virbac; Jinyu Bio-Technology; ChengDu Tecbond; CHOONGANG VACCINE; FATRO
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Agricultural Animal Vaccine Segmentation Breakdown10 items

Application

Cow

Sheep

Swine

Chicken

Others

Types

Live Attenuated Vaccines

Inactivated Vaccines

Others

Regional Insights

Loading chart…

Competitive Landscape

Merck: regional expansion

Zoetis: premium pricing

Boehringer Ingelheim: innovation pipeline

Ceva Corporate: local manufacturing

HVRI: OEM tie-ups

Ringpu Biology: vertical integration

Key Agricultural Animal Vaccine Companies13 items

Merck

Zoetis

Boehringer Ingelheim

Ceva Corporate

HVRI

Ringpu Biology

Yebio Bioengineering

Guangdong Wenshi Dahuanong Biotechnology

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CHOONGANG VACCINE

FATRO

Market Ecosystem

Raw material suppliers — providing vaccine components

Technology providers — developing vaccine technologies

OEMs/manufacturers — producing animal vaccines

Distributors/channel partners — delivering vaccines to end users

Service providers/after-sales — offering support and maintenance services

End users/buyers — utilizing animal vaccines in agricultural settings

Regulators/standards bodies — establishing and enforcing vaccine standards

Recent Industry Insights

Analyst Overview

Table of Contents